Acadia Pharmaceuticals | ACAD - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Acadia Pharmaceuticals

Acadia Pharmaceuticals reported $-44939000 in Pre-Tax Profit for its fiscal quarter ending in March of 2023.


Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -44939000 4.05M
Alnylam Pharmaceuticals ALNY:US USD -172362000 34.66M
Cara Therapeutics CARA:US USD -26665000 3.67M
Eisai 4523:JP JPY 27.42B 17.97B
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
Intra Cellular Therapies ITCI:US USD -44043000 17K
J&J JNJ:US USD 8.47B 1.05B
Marinus Pharmaceuticals MRNS:US USD -34730000 2.05M
Neurocrine Biosciences NBIX:US USD -103300000 221.2M
Prothena PRTA:US USD -49776000 53.12M
PTC Therapeutics PTCT:US USD -134990000 21.32M
Sarepta Therapeutics SRPT:US USD -512710000 411.4M
Seattle Genetics SGEN:US USD -170113000 26.28M
Ultragenyx Pharmaceutical RARE:US USD -163477000 10.19M